Health Quality Ontario Recommendations re: Remote Monitoring of Cardiac Devices and Transcatheter aortic valve implantation (TAVI)

Late last year, Health Quality Ontario, under the guidance of the Ontario Health Technology Advisory Committee, recommended publicly funding remote monitoring for patients with implantable cardioverter-defibrillators, cardiac resynchronization therapy devices with or without a defibrillator, and permanent pacemakers.  For more information, click here: https://bit.ly/2F5oRiZ.

HQO also recommended publicly funding transcatheter aortic valve implantation (TAVI) in patients with severe, symptomatic aortic valve stenosis who are at intermediate surgical risk.  For more information, click here: https://bit.ly/2CQXIy1.

In both cases, HQO asked the OAC to provide experts in these fields to assist with the health technology assessment and consulted us on the draft recommendations before they were finalized.